# FDA 483 - Biovectra, Inc. - August 26, 2022

Source: https://www.globalkeysolutions.net/records/483/biovectra-inc/a9e6f5c1-5f2f-405e-8e41-a3422f6d1306

> FDA 483 for Biovectra, Inc. on August 26, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Biovectra, Inc.
- Inspection Date: 2022-08-26
- Product Type: drugs
- Office Name: Office of Pharmaceutical Quality Operations

## Related Documents

- [483 - 2017-02-17](https://www.globalkeysolutions.net/records/483/biovectra-inc/773a5858-5c4c-456e-bdf5-e703c5faaff7)
- [483 - 2024-04-19](https://www.globalkeysolutions.net/records/483/biovectra-inc/f876d21b-ffcd-4001-af36-2c6b587572d0)

## Related Officers

- [Program Division Director/District Director](https://www.globalkeysolutions.net/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)

Company: https://www.globalkeysolutions.net/companies/biovectra-inc/1e29a998-319e-49cb-bee2-bacea2c620ef

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations/6b0153a9-c1d1-46a5-8b10-836d2ae44ffe